Indianapolis-based Indiana University Health and Raleigh, N.C.-based WakeMed Health & Hospitals are collaborating with blockchain and pharmacy companies to better track prescriptions.
The two health systems will adopt a blockchain solution that aims at tracking prescriptions across provider locations within their respective networks. The blockchain tool will also be leveraged to address regional inventory shortages.
As part of the multiregional pilot study, which was granted FDA approval, blockchain developer Rymedi and pharmacy companies Temptime and Good Shepherd Pharmacy as well as the Center for Supply Chain Studies and the Global Health Policy Institute are working with the health systems to enable blockchain technology to verify specialty prescription drugs.
The study is targeting intra- and inter-health system medication transport and usage in North Carolina, Indiana and Tennessee through the application of blockchain technology.
WakeMed and IU Health will adopt Rymedi’s immutable supply and multipartner data platforms. These tools track medicines from wholesale distributors and third-party logistics providers.
The Center for Supply Chain Studies and the Global Health Policy Institute at UC San Diego will provide design and evaluation support to optimize the pilot’s impact on policy and industry standards development.
Good Shepherd Pharmacy and its associated RemediChain project will take the lessons learned from IU Health and WakeMed as they develop a solution to connect patients to prescriptions they would otherwise not be able to afford.
More articles about health IT:
Baystate Health hit with class-action suit after phishing attack exposed 12,000 patients
NYC lab director fired after raising concerns about DNA test methods wins $1M settlement
Robotic catheter autonomously navigates a beating heart